Abstract LB214: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Heather Shaw, Poulam Patel, Miranda Payne, Satish Kumar, Sarah Danson, Martin Highley, Clare Barlow, Prasad Kellati, Ioannis Karydis, Maria Marples, Kate Young, Pippa Corrie, Robert Miller, Georgia Goodhew, Samantha Paston, Gaelle Cane, Joseph Chadwick, Sabaria Shah, Lindy G. Durrant, Nermeen Varawalla
Institutions: Mount Vernon Cancer Centre, Nottingham University Hospitals NHS Trust, Churchill Hospital, University of Oxford, Velindre Cancer Centre, Weston Park Cancer Centre, Derriford Hospital, Musgrove Park Hospital, Royal Preston Hospital, Southampton General Hospital, Royal Marsden Hospital, Addenbrooke's Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409821239